AVIR Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment VIK Q1 2026 Earnings Narrower Loss Beats Estimates Stock Surges Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline GRNQ Q1 2024 Earnings Loss Per Share of 004 as Stock Declines Over 5 WDS Q4 2025 Earnings EPS Beats Estimates by 338 as Strong Operational Performance Outweighs Weak Revenue Environment CSV Q1 2026 Earnings EPS Slightly Beats Estimates Amid Mixed Signals Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage STWD Q1 2026 Earnings EPS Misses Estimates as Real Estate Challenges Persist Gulf Resources Inc Q3 2023 Earnings Deepening Loss Amidst Opaque Reporting Okta Inc OKTA Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Revenue Ambiguity OLMA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues TXMD Q3 2023 Earnings EPS Misses Estimates Stock Declines Afya Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower